Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.

Cooper PD, Petrovsky N.

Glycobiology. 2011 May;21(5):595-606. doi: 10.1093/glycob/cwq201. Epub 2010 Dec 7.

2.

Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.

Cooper PD, Barclay TG, Ginic-Markovic M, Petrovsky N.

Vaccine. 2014 Jan 23;32(5):552-7. doi: 10.1016/j.vaccine.2013.11.105. Epub 2013 Dec 14.

3.

The polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.

Cooper PD, Barclay TG, Ginic-Markovic M, Petrovsky N.

Glycobiology. 2013 Oct;23(10):1164-74. doi: 10.1093/glycob/cwt053. Epub 2013 Jul 12.

4.

Vaccine adjuvants based on gamma inulin.

Cooper PD.

Pharm Biotechnol. 1995;6:559-80. Review.

PMID:
7551236
5.

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.

Petrovsky N, Cooper PD.

Vaccine. 2015 Nov 4;33(44):5920-6. doi: 10.1016/j.vaccine.2015.09.030. Epub 2015 Sep 25. Review.

7.

Anti-complementary action of polymorphic "solubility forms" of particulate inulin.

Cooper PD, Carter M.

Mol Immunol. 1986 Aug;23(8):895-901.

PMID:
3796631
8.

Development of soluble inulin microparticles as a potent and safe vaccine adjuvant and delivery system.

Kumar S, Tummala H.

Mol Pharm. 2013 May 6;10(5):1845-53. doi: 10.1021/mp3006374. Epub 2013 Apr 10.

PMID:
23506468
9.

Investigation of the biodistribution, breakdown and excretion of delta inulin adjuvant.

Wang L, Barclay T, Song Y, Joyce P, Sakala IG, Petrovsky N, Garg S.

Vaccine. 2017 Aug 3;35(34):4382-4388. doi: 10.1016/j.vaccine.2017.06.045. Epub 2017 Jul 1.

PMID:
28676380
10.

Physical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation.

Barclay TG, Rajapaksha H, Thilagam A, Qian G, Ginic-Markovic M, Cooper PD, Gerson A, Petrovsky N.

Carbohydr Polym. 2016 Jun 5;143:108-15. doi: 10.1016/j.carbpol.2016.01.062. Epub 2016 Jan 29.

11.

Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants.

Lu F, Mencia A, Bi L, Taylor A, Yao Y, HogenEsch H.

J Control Release. 2015 Apr 28;204:51-9. doi: 10.1016/j.jconrel.2015.03.002. Epub 2015 Mar 3.

PMID:
25747143
12.

Enrichment of higher molecular weight fractions in inulin.

Moerman FT, Van Leeuwen MB, Delcour JA.

J Agric Food Chem. 2004 Jun 16;52(12):3780-3.

PMID:
15186097
13.

Molecular properties and prebiotic effect of inulin obtained from artichoke (Cynara scolymus L.).

López-Molina D, Navarro-Martínez MD, Rojas Melgarejo F, Hiner AN, Chazarra S, Rodríguez-López JN.

Phytochemistry. 2005 Jun;66(12):1476-84.

PMID:
15960982
14.

Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.

Gupta A, Khajuria A, Singh J, Singh S, Suri KA, Qazi GN.

Int Immunopharmacol. 2011 Aug;11(8):968-75. doi: 10.1016/j.intimp.2011.02.011. Epub 2011 Mar 1.

PMID:
21371582
15.

Bacterial c-di-GMP is an immunostimulatory molecule.

Karaolis DK, Means TK, Yang D, Takahashi M, Yoshimura T, Muraille E, Philpott D, Schroeder JT, Hyodo M, Hayakawa Y, Talbot BG, Brouillette E, Malouin F.

J Immunol. 2007 Feb 15;178(4):2171-81.

16.

Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis.

Silva BP, Soares JB, Souza EP, Palatnik M, Sousa CB, Parente JP.

Vaccine. 2005 Jan 11;23(8):1061-71.

PMID:
15620480
17.

The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant.

Libanova R, Ebensen T, Schulze K, Bruhn D, Nörder M, Yevsa T, Morr M, Guzmán CA.

Vaccine. 2010 Mar 2;28(10):2249-58. doi: 10.1016/j.vaccine.2009.12.045. Epub 2010 Jan 7. Erratum in: Vaccine. 2010 Apr 30;28(20):3625.

PMID:
20060510
18.

Pinellic acid from the tuber of Pinellia ternata Breitenbach as an effective oral adjuvant for nasal influenza vaccine.

Nagai T, Kiyohara H, Munakata K, Shirahata T, Sunazuka T, Harigaya Y, Yamada H.

Int Immunopharmacol. 2002 Jul;2(8):1183-93.

PMID:
12349955
19.

Fructo-oligosaccharide production from inulin through partial citric or phosphoric acid hydrolyses.

Fontana JD, Grzybowski A, Tiboni M, Passos M.

J Med Food. 2011 Nov;14(11):1425-30. doi: 10.1089/jmf.2010.0273. Epub 2011 Jun 11.

PMID:
21663491
20.

Short-chain fructo-oligosaccharide and inulin modulate inflammatory responses and microbial communities in Caco2-bbe cells and in a mouse model of intestinal injury.

Johnson-Henry KC, Pinnell LJ, Waskow AM, Irrazabal T, Martin A, Hausner M, Sherman PM.

J Nutr. 2014 Nov;144(11):1725-33. doi: 10.3945/jn.114.195081. Epub 2014 Aug 20.

PMID:
25143376

Supplemental Content

Support Center